Virginia Rhum

• Product sales and promotion of Vraylar and Viibryd to psychiatrists, neurologists, psychiatric nurse practitioners, and primary care providers based in community mental health clinics, private practice, and inpatient/outpatient units and hospital systems.
• Specializing in utilization growth for product/indication launches, disease state and MOA education, patient advocacy, brand loyalty, and cultivating long-term relationships with customers.
• Selected for regional leadership team and the role of AbbVie Company Ambassador for the region.
• Mentor for new representatives across the division and region.
• Member of Women Leaders in Action, employee resource group.
• Annual Reviews consistently at exceeds expectations.
• Sales performance rankings in the top 25%

• Promotion and sales of medical device Liletta to OBGYNs and other women's health specialty health care providers. Presented product and buy and bill contracts to purchasing managers, pharmacists, and physicians in hospital systems, and independent offices. Submitted and maintained purchase order contracts and monitored supply in customer offices.
• Conducted in-services and training on use and application of medical device.
• Promotion of pharmaceutical products LoLoestrin, Taytulla, and Estrace to OBGYNs, nurse practioners, and primary care providers.
• Asked by the company to take on this temporary role for the remaining duration of the women's health account specialty team, then came back to psychiatry specialty sales.
• Ranked in the top 20% in the quarters for this role.

• Promoted to Specialty Representative to launch Vraylar and maintain sales of Viibryd.
• Responsible for product sales growth, product and disease state awareness education with psychiatrists, neurologists, nurse practioners, and primary care providers.
• Recruited advocate speakers and conducted over 50 programs in the first year of promotion.
• Facilitated company sponsorship and participation in local and regional health care provider conferences, including CAPNI and the Regional Integrated Mental Health Conference.
• Maximized compensation in launch contests and 2016 President's Club contender.

Launch and promotion of multiple products in several specialty markets including psychiatry, neurology, primary care, cardiology, gastroenterolgy, rheumatology, pain management, and women's health.

• Lexapro an SSRI for major depressive disorder in adults and adolescents, and generalized anxiety disorder.
• Aerobid inhaler for the maintenance treatment of asthma.
• Combunox an oxycodone/ibuprophen combination for pain management.
• Namenda/ Namenda XR a novel NMDA receptor antagonist and Namzaric a fixed dose combination treatment of namenda and aricept for the management of Alzheimer's Disease.
• Bystolic a vasodialating beta blocker for hypertension management.
• Linzess for chronic idopathic constipation and IBS-C.
• Viibryd a novel serotonin modulater for major depressive disorder.
• Fetzima an SNRI for the treatment of major depressive disorder.
• Savella an SNRI for the treatment of Fibromyalgia.
• Saphris for bipolor 1 disorder manic or mixed episodes and schizophrenia.
• Rankings finished in the top 25% of the company 9 out of 12 years and in the top 10% of the company in 5 of those years.
• Helped to train several new representatives over the years, specifically, hosted field rides with colleagues to exemplify a job well done in sales calls, building relationships in target offices, territory management, team communication, and product knowledge.
• Have consistently demonstrated leadership on my current team with regards to business ownership of the territory. This includes strategy and execution of messaging, relationships, activity, and communication for each target. Self-assessment and critical thinking are other instrumental ways that I produce quick growth results and achieve goals.
• Maximized career pathways program to achieve Executive Sales Representative IV within the role of Sales Representative.